background: non obstructive azoospermia (noa) is one of the causes of male infertility in which spermatogenesis process is disturbed. recent studies suggested the possible role of endothelial nitric oxide synthase (enos) in spermatogenesis process. objective: the aim of the present study is to evaluate the expression of enos in human testicular tissue in men with noa and men with normal spermat...

Factors other than spermatozoa could be the major determinant of the success of assisted reproduction treatment in cases of male infertility. Our aim was to evaluate the effect of the wife's age and ovarian reserve on assisted reproduction success rates in the most severe type of male infertility, i.e. azoospermia. A total of 249 consecutive couples suffering from male infertility caused by azo...

Obstructive azoospermia is a relatively common male infertility condition. The main etiologies of obstructive azoospermia include congenital, surgical-derived, traumatic and post-infectious cases. Although seminal tract reconstruction is a cost-effective treatment in most cases, this approach may not be feasible or desired in some cases. In such cases, assisted reproduction techniques offer a m...

PURPOSE We examined the relationship between L-PGDS (lipocalin-type prostaglandin D synthase) levels in seminal plasma and the presence or absence of obstruction in the male seminal tract. MATERIALS AND METHODS Semen samples were collected and analyzed from 1) 10 patients with normal semen parameters, 2) 9 with obstructive azoospermia, 3) 20 after vasectomy and 4) 14 with nonobstructive azoos...

OBJECTIVE Aproximately 10% of patients with non-obstructive azoospermia and 5% with non-obstructive severe oligozoospermia carry AZF region microdeletions (AZoospermic Factor) in the Y chromosome. The aim of this study is to analize the clinical and pathological findings in this group of patients and compare them with the previous evidence. MATERIAL AND METHODS Retrospective study of 11 patie...

It has been proposed that the genetic variants of IVS8 c.1210-12T[5_9] and adjacent c.1210-35_1210-12GT[8_12] in cystic fibrosis transmembrane conductance regulator gene might contribute to the spermatogenetic failure, but numerous genetic association studies that aimed to test this hypothesis reported conflicting results. So, in order to clarify such inconsistencies, we first conducted an orig...

Background: Around 10 % of infertile men and 1 percent all males have azoospermia. There are two types azoospermia, which obstructive non-obstructive Non-obstructive azoospermia's main mechanism is because the testes fail to produce sex hormone induce spermatogenesis (primary testicular failure).
 Case: A patient 28 years old has a job as car paint worker. He came with chief complaint infe...

BACKGROUND TEX101 is a cell membrane protein exclusively expressed by testicular germ cells and shed into seminal plasma. We previously verified human TEX101 as a biomarker for the differential diagnosis of azoospermia, and developed a first-of-its-kind TEX101 ELISA. To demonstrate the clinical utility of TEX101, in this work we aimed at evaluating ELISA performance in a large population of fer...

Background: During the later stages of spermatogenesis, spermatid nuclear remodeling and condensation are associated with histone modifications and the sequential displacement of histones by transition proteins and then by protamines. In humans, approximately 15% of the sperm DNA remains packaged by histones in sequence-specific areas. The histone variant H2B, member W, testis-specific (H2BFWT)...

The aim was to determine whether proton magnetic resonance spectroscopy (1H-MRS) of metabolites such as glycerophosphorylcholine (GPC), choline, citrate and lactate in human seminal plasma can be used to differentiate (i) different azoospermic patients and (ii) different forms of spermatogenic failure including those who had undergone radiation therapy or chemotherapy. Semen samples were provid...